Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
This clinical trial update notes termination of a Stanford-sponsored study evaluating C-arm CT during transarterial chemoembolization for he…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial comparing RAD001 (everolimus) with sunitinib as first-line and second-line therapy for metastatic renal cell carcinoma has c…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer [Phase 2]
Phase 2 trial investigating chemotherapy followed by ESO-1 lymphocytes and aldesleukin in metastatic cancer was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy [Phase 3]
Phase 3 study evaluating bevacizumab (Avastin) added to interferon alfa-2a in metastatic renal cell carcinoma after nephrectomy; trial statu…
-
FDA approval · 2016-06-16FDA Approved: INLYTA — Supplemental Application (U.S. Pharmaceuticals)
FDA approved a supplemental application for INLYTA (axitinib) submitted by U.S. Pharmaceuticals. This action updates the drug’s labeling for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of temsirolimus and vinorelbine ditartrate in adults with unresectable or metastatic solid tumors…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating everolimus as second-line therapy in metastatic renal cell carcinoma has been completed, with results post…
-
CLINICAL_TRIALS research · 2016-06-02Clinical Trial Update: DC1s-CTL Cellular Therapy for Renal Cell Carcinoma [Phase 1, Phase 2]
This update covers a Phase 1/2 clinical trial of DC1s-CTL cellular therapy for renal cell carcinoma, with current status not disclosed.
-
FDA approval · 2016-05-20FDA Approved: VOTRIENT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for VOTRIENT (pazopanib hydrochloride) filed by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors [Phase 1]
Completed Phase 1 multicenter dose-escalation study evaluating the combination of pazopanib and bevacizumab in patients with metastatic rena…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients. [Phase 2]
A Phase 2, one-arm exploratory trial evaluating apatinib in patients with advanced/metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy with prednisone for recurrent/metastatic kidney cancer has completed. The study status is …
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer [Phase 2]
Phase 2 trial of sunitinib malate in patients with non-clear cell renal cell carcinoma has completed and results have been posted.
-
CLINICAL_TRIALS research · 2016-05-03Clinical Trial Update: Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage [NA]
A clinical trial entry for zero ischemia laparoscopic radiofrequency/microwave ablation assisted enucleation of renal cell carcinoma at T1 s…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025) [Phase 3]
A Phase 3 trial comparing nivolumab versus everolimus in previously treated advanced or metastatic clear-cell renal cell carcinoma has compl…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
This clinical trial update reports a completed retrospective study of temsirolimus in renal cell carcinoma and mantle cell lymphoma. Results…
-
CLINICAL_TRIALS research · 2016-04-26Clinical Trial Update: Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC） [Phase 2]
A Phase II clinical trial comparing anlotinib versus sunitinib in patients with advanced renal cell carcinoma; the current status of the stu…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2 [Phase 2]
Phase 2 study of irradiated donor lymphocyte infusion plus high-dose interleukin-2 for metastatic melanoma and renal cell carcinoma was term…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies [Phase 1]
Phase 1 study of nivolumab (BMS-936558) in advanced or recurrent malignancies completed; results posted.
-
FDA approval · 2016-03-30FDA Approved: INLYTA — Supplemental Application (U.S. Pharmaceuticals)
The FDA approved a supplemental application for INLYTA (axitinib) submitted by U.S. Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: AMG 172 First in Human Study in Patients With Kidney Cancer [Phase 1]
A first-in-human Phase 1 trial of AMG 172 in patients with kidney cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2016-03-24Clinical Trial Update: Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma [Phase 2]
A clinical trial evaluating bevacizumab with or without sunitinib in sunitinib-refractory renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib [Phase 2]
This document reports the completion of a Phase 2 trial of AMG 386 in combination with sorafenib for first-line advanced renal cell carcinom…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal [Phase 2]
Phase 2 trial update on Everolimus (RAD001) for advanced renal cell carcinoma prior to nephrectomy; the study was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer [Phase 2]
Phase 2 safety study comparing TroVax alone versus TroVax plus Interferon Alpha in patients with renal cell carcinoma; the trial status is c…